Click on headlines below to download research

Inecalcitol shows promise in CML, R&D refocus
Hybrigenics | 12/05/2017

Hybrigenics’ main focus is the development of inecalcitol as a niche treatment for leukaemia. In February it presented encouraging initial results…

Encouraging initial CML clinical data
Hybrigenics | 17/02/2017

Hybrigenics has presented the first ever clinical data from an interim analysis of a Phase II study of inecalcitol in combination with imatinib in patients…